Genesis Healthcare Inc (NYSE:GEN) EVP Joanne Susan Reifsnyder sold 4,877 shares of the company’s stock in a transaction dated Tuesday, June 12th. The stock was sold at an average price of $2.28, for a total transaction of $11,119.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Joanne Susan Reifsnyder also recently made the following trade(s):
- On Tuesday, June 5th, Joanne Susan Reifsnyder sold 7,488 shares of Genesis Healthcare stock. The stock was sold at an average price of $2.19, for a total transaction of $16,398.72.
Shares of NYSE GEN traded up $0.25 during mid-day trading on Thursday, reaching $2.65. The company had a trading volume of 1,813,858 shares, compared to its average volume of 714,116. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of -2.80. The stock has a market cap of $366.72 million, a PE ratio of -1.27 and a beta of 1.00. Genesis Healthcare Inc has a 52 week low of $0.60 and a 52 week high of $2.70.
A number of institutional investors have recently modified their holdings of the business. Millennium Management LLC grew its holdings in Genesis Healthcare by 40.6% during the 1st quarter. Millennium Management LLC now owns 338,678 shares of the company’s stock worth $511,000 after acquiring an additional 97,834 shares in the last quarter. V3 Capital Management L.P. grew its holdings in Genesis Healthcare by 12.5% during the 1st quarter. V3 Capital Management L.P. now owns 2,544,608 shares of the company’s stock worth $3,842,000 after acquiring an additional 282,709 shares in the last quarter. California Public Employees Retirement System grew its holdings in Genesis Healthcare by 23.3% during the 1st quarter. California Public Employees Retirement System now owns 309,910 shares of the company’s stock worth $468,000 after acquiring an additional 58,610 shares in the last quarter. BSW Wealth Partners grew its holdings in Genesis Healthcare by 74.2% during the 1st quarter. BSW Wealth Partners now owns 115,000 shares of the company’s stock worth $174,000 after acquiring an additional 49,000 shares in the last quarter. Finally, BlackRock Inc. grew its holdings in Genesis Healthcare by 5.8% during the 1st quarter. BlackRock Inc. now owns 2,302,417 shares of the company’s stock worth $3,476,000 after acquiring an additional 127,118 shares in the last quarter. Institutional investors own 18.70% of the company’s stock.
A number of research analysts have recently commented on the stock. Stifel Nicolaus set a $2.00 price target on shares of Genesis Healthcare and gave the stock a “hold” rating in a report on Tuesday, April 24th. ValuEngine cut shares of Genesis Healthcare from a “buy” rating to a “hold” rating in a report on Monday, April 2nd. Finally, Stephens restated a “hold” rating and issued a $2.00 price target on shares of Genesis Healthcare in a report on Monday, March 19th. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $2.00.
Genesis Healthcare Company Profile
Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.
Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.